Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Other Solid Tumors

PET imaging of fibroblast activation protein in various types of cancers by using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a single-center, prospective study

Yizhen Pang, Liang Zhao, Weizhi Xu, Jianhao Chen, Hua Wu, Qin Lin, Long Sun and Haojun Chen
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P764;
Yizhen Pang
1Xiamen University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liang Zhao
2The First Affiliated Hospital of Xiamen University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weizhi Xu
1Xiamen University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianhao Chen
2The First Affiliated Hospital of Xiamen University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hua Wu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qin Lin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Long Sun
3Department of Nuclear MedicineThe First Affiliated Hospital of Xiamen University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haojun Chen
2The First Affiliated Hospital of Xiamen University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 64 no. supplement 1 P764

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 28, 2023.

Copyright & Usage 
© 2023

Author Information

  1. Yizhen Pang1,
  2. Liang Zhao2,
  3. Weizhi Xu1,
  4. Jianhao Chen2,
  5. Hua Wu,
  6. Qin Lin,
  7. Long Sun3 and
  8. Haojun Chen2
  1. 1Xiamen University
  2. 2The First Affiliated Hospital of Xiamen University
  3. 3Department of Nuclear MedicineThe First Affiliated Hospital of Xiamen University

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: September 2023 to April 2025

AbstractFullPdf
Sep 20232300
Oct 20231000
Nov 20233000
Dec 20232800
Jan 20241700
Feb 20241800
Mar 20242100
Apr 20244900
May 20242300
Jun 20243800
Jul 202410500
Aug 20248400
Sep 20242000
Oct 20241500
Nov 20241500
Dec 20241600
Jan 2025600
Feb 20251600
Mar 2025700
Apr 20251500
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PET imaging of fibroblast activation protein in various types of cancers by using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a single-center, prospective study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PET imaging of fibroblast activation protein in various types of cancers by using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a single-center, prospective study
Yizhen Pang, Liang Zhao, Weizhi Xu, Jianhao Chen, Hua Wu, Qin Lin, Long Sun, Haojun Chen
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P764;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PET imaging of fibroblast activation protein in various types of cancers by using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a single-center, prospective study
Yizhen Pang, Liang Zhao, Weizhi Xu, Jianhao Chen, Hua Wu, Qin Lin, Long Sun, Haojun Chen
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P764;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Impact of dual tracer study to differentiate malignant vs benign peritoneal diseases.
  • Radiation Absorbed Dose to Spinal Cord: Therapy of Leptomeningeal Metastasis Using Beta-Emission Radiopharmaceuticals
  • Initial Clinical Experience with 177Lu-EB-FAPI Radioligand Therapy in Patients with End-Stage Metastatic Cancers
Show more Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Other Solid Tumors

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire